[HTML][HTML] Role of the CXCL8-CXCR1/2 axis in cancer and inflammatory diseases

H Ha, B Debnath, N Neamati - Theranostics, 2017 - ncbi.nlm.nih.gov
The chemokine receptors CXCR1/2 and their ligand CXCL8 are essential for the activation
and trafficking of inflammatory mediators as well as tumor progression and metastasis. The …

[HTML][HTML] Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases

Y Cheng, X Ma, Y Wei, XW Wei - … et Biophysica Acta (BBA)-Reviews on …, 2019 - Elsevier
The chemokine receptor CXCR2 and its ligands are implicated in the progression of tumours
and various inflammatory diseases. Activation of the CXCLs/CXCR2 axis activates multiple …

Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis

N Kakiuchi, K Yoshida, M Uchino, T Kihara, K Akaki… - Nature, 2020 - nature.com
Chronic inflammation is accompanied by recurring cycles of tissue destruction and repair
and is associated with an increased risk of cancer,–. However, how such cycles affect the …

The role of the polymeric immunoglobulin receptor and secretory immunoglobulins during mucosal infection and immunity

H Turula, CE Wobus - Viruses, 2018 - mdpi.com
The gastrointestinal tract houses millions of microbes, and thus has evolved several host
defense mechanisms to keep them at bay, and prevent their entry into the host. One such …

Role of polymeric immunoglobulin receptor in IgA and IgM transcytosis

H Wei, JY Wang - International Journal of Molecular Sciences, 2021 - mdpi.com
Transcytosis of polymeric IgA and IgM from the basolateral surface to the apical side of the
epithelium and subsequent secretion into mucosal fluids are mediated by the polymeric …

A20/tumor necrosis factor α-induced protein 3 in immune cells controls development of autoinflammation and autoimmunity: lessons from mouse models

T Das, Z Chen, RW Hendriks, M Kool - Frontiers in immunology, 2018 - frontiersin.org
Immune cell activation is a stringently regulated process, as exaggerated innate and
adaptive immune responses can lead to autoinflammatory and autoimmune diseases …

[HTML][HTML] CXCL8 chemokine in ulcerative colitis

Y Zhu, S Yang, N Zhao, C Liu, F Zhang, Y Guo… - Biomedicine & …, 2021 - Elsevier
Ulcerative colitis (UC) is a major type of inflammatory bowel disease (IBD), which is
characterized by diffuse inflammation of the mucosa of the colon and rectum. Abdominal …

local tumor necrosis factor-α inhibition in inflammatory bowel disease

B Gareb, AT Otten, HW Frijlink, G Dijkstra… - Pharmaceutics, 2020 - mdpi.com
Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD)
characterized by intestinal inflammation. Increased intestinal levels of the proinflammatory …

A20: A multifunctional tool for regulating immunity and preventing disease

BA Malynn, A Ma - Cellular immunology, 2019 - Elsevier
A20, also known as TNFAIP3, is a potent regulator of ubiquitin (Ub) dependent signals. A20
prevents multiple human diseases, indicating that the critical functions of this protein are …

Protection against ulcerative colitis and colorectal cancer by evodiamine via anti‑inflammatory effects

Y Zhang, Y Zhang, Y Zhao, W Wu… - Molecular …, 2022 - spandidos-publications.com
Evodiamine (Evo) is an alkaloid that can be extracted from the berry fruit Evodia rutaecarpa
and has been reported to exert various pharmacological effects, such as antidiarrheal …